Conditions: Rheumatoid Arthritis
Keywords: Cholesterol metabolism Cholesterol flux Rheumatoid Arthritis Tasocitinib CP-690 550
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 69
Healthy volunteers: yes

Brief summary:
The purpose of study is to explore the effect of CP-690,550 (tasocitinib) on cholesterol metabolism in patients with active rheumatoid arthritis (RA).

Detailed description:

Arms:
arm 1: None arm 2: No intervention

Interventions: intervention 1: CP-690,550 (tasocitinib)
Intervention descriptions: intervention 1: CP-690,550 (tasocitinib) dosed at 10 mg BID for 6 weeks in patients with active rheumatoid arthritis

Protocol document: